GENE ONLINE|News &
Opinion
Blog

EMA Approval
Atara, Pierre Fabre’s EBV T-Cell Therapy Recommended For Approval In Europe
2022-10-17
EMA Begins Regulatory Review For Astellas’ Fezolinetant
2022-10-03
Merck’s Vaccine For Streptococcus Pneumoniae Lined Up for Another European Commission Approval
2022-09-16
Gilead’s Novel Capsid Inhibitor Treatment for HIV Gains First Approval from European Commission
2022-08-22
Oncopeptides’ Pepaxti Won EMA Approval for Multiple Myeloma
2022-08-19
Applications for Medicine Treating Crohn’s Disease Submitted to EMA and FDA
2022-07-29
BioMarin Wins First Gene Therapy Recommendation For Hemophilia A in Europe
2022-06-27
Bio-Europe Spring: 2022 Europe Ophthalmic Medication Market Skyrockets
2022-04-20
EMA Begins Review of BeiGene, Novartis’s PD-1 Antibody for Esophageal and Lung Cancer
2022-04-13
Good or Bad: The 4th Dose of mRNA COVID Vaccine
2022-04-12
EMA Accepts Application for AstraZeneca’s Anti-RSV Antibody Nirsevimab.
2022-02-21
Atara Biotherapeutics’ First-In-Class Allogeneic T-Cell Therapy Accepted for EMA Review
2021-12-02
GIVLAARI to Enter European Market Following EMA Approval
2020-03-04
LATEST
Revolutionary Technology Aims to Detect and Prevent Dementia and Mental Illness
2023-09-22
Connecting Global Biotech, Thailand’s Largest Biotech Event Takes Center Stage
2023-09-22
BIOHK2023: A place where biotechnology meets financial economics
2023-09-21
Connecting the Dots: TCELS Leads the Way for Thailand’s Life Sciences and Healthcare Innovations
2023-09-20
Deceptive Health Advice on TikTok Raises Concerns About Gynecologic Cancer Misinformation
2023-09-20
Dreams and Nightmares: the Mysterious Activities of the Brain During Deep Sleep
2023-09-20
GeneOnline’s Weekly News Highlights: Sept 11-Sept 15
2023-09-19
EVENT
2023-10-04
BioFuture 2023
New York city,USA
Scroll to Top